Biomarkers in Oncology

Biomarkers play an important role in oncology that is used in clinical research for risk assessment, differential diagnosis, determination of the nature of tumors, for detection purposes, to determine the prognosis and dose-response of the drug to the treatment. The process indicative of the presence of cancer in the body is carried out by means of tools known as cancer biomarkers. There are different types of cancer in which biomarkers have their application, such as lung, melanoma, breast, colorectal, pancreas and many more. Biochemically, cancer biomarkers can be DNA, RNA, proteins, peptides, hormones, metabolites and even biological processes such as apoptosis, angiogenesis or proliferation. There are three main types of cancer biomarkers depending on their clinical use: prognostic, predictive and pharmacodynamics markers.

 

  • Cancer Biomarkers in clinical research
  • Diagnosis and treatment
  • Cervical Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Prostate cancer
  • Lung Cancer

Related Conference of Biomarkers in Oncology

November 07-08, 2018

3rd International Conference on Applied Crystallography

Atlanta, Georgia, USA
January 28-29, 2019

10th Asia Pacific Congress on Polymer Science and Engineering

Seoul, South Korea
February 18-20, 2019

16th Annual Congress on

Materials Research and Technology

Amsterdam, Netherlands
March 11-12, 2019

5th Annual Conference on Biomaterials

Nice, France
March 25-26, 2019

19th International Conference and Exhibition on Materials Science and Engineering

March 25-26, 2019 Yokohama, Japan
April 24-25, 2019

World Congress on Nanomaterials and Nanotechnology

Budapest | Hungary
July 22-23, 2019

35th World Congress on Materials Science and Nanotechnology

Melbourne, Australia

Biomarkers in Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in